Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.7 USD | +0.30% | +0.45% | +101.81% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 176M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -32M | EV / Sales 2024 * | - |
Net cash position 2024 * | 119K | Net Debt 2025 * | 50M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.98
x | P/E ratio 2025 * |
-9.24
x | Employees | 140 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 25.63% |
Latest transcript on Rani Therapeutics Holdings, Inc.
1 day | +0.30% | ||
1 week | +0.45% | ||
Current month | +115.43% | ||
1 month | +115.43% | ||
3 months | +86.63% | ||
6 months | +242.71% | ||
Current year | +101.81% |
Managers | Title | Age | Since |
---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 43 | 21-05-31 |
Mir Imran
FOU | Founder | 68 | 21-04-05 |
Svai Sanford
DFI | Director of Finance/CFO | 53 | 21-04-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laureen DeBuono
BRD | Director/Board Member | 66 | 21-04-05 |
Jean-Luc Butel
BRD | Director/Board Member | 67 | 21-04-05 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 21-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 6.7 | +0.30% | 60,421 |
24-04-26 | 6.68 | +1.83% | 42,500 |
24-04-25 | 6.56 | -6.15% | 189,613 |
24-04-24 | 6.99 | +4.48% | 138,491 |
24-04-23 | 6.69 | +0.30% | 92,585 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+101.81% | 176M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.92% | 22.18B | |
-16.67% | 21.2B | |
-7.56% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- RANI Stock